BOISE -- Idaho will be getting nearly $2 million as part of two multi-state settlements with a pharmaceutical company accused of illegally marketing anti-psychotic drugs.
Attorney General Lawrence Wasden announced a $1.2 million settlement Monday with Abbott Laboratories. Then on Tuesday, the state settled a second claim with the company for $760,000.
The company has been sued by 44 states and the District of Columbia over its marketing of Depakote, which is used to treat seizure disorders, migraines and mania associated with bi-polar disorder.
States complained the company engaged in unfair and deceptive strategies to market Depakote for off-label uses without evidence proving it can be prescribed for those uses.
The second settlement focused on Abbott marketing the drug for uses federal officials had not deemed safe, leading to false Medicaid claims.